Woman with Three Autoimmune Diseases Makes 'Remarkable' Recovery After Cell Therapy
A woman who endured three distinct life-threatening autoimmune diseases for over a decade has experienced a remarkable recovery following a pioneering cell therapy that effectively reset her immune system. The 47-year-old patient, previously reliant on daily blood infusions and blood-thinning medications, had exhausted nine different treatments before undergoing the innovative therapy at University Hospital Erlangen in Germany last year.
Swift and Significant Improvement in Health
Within weeks of receiving the treatment, her autoimmune conditions began to respond positively. For just over a year now, she has been in a state of treatment-free remission, which doctors report has significantly enhanced her quality of life. "The treatment was extremely efficient in getting rid of all three autoimmune conditions at once," stated Dr. Fabian Müller, the corresponding author from the University Hospital of Erlangen.
The patient suffered from a trio of severe autoimmune disorders:
- Autoimmune haemolytic anaemia (AIHA): A condition where the immune system mistakenly attacks and destroys red blood cells.
- Immune thrombocytopenia (ITP): A disorder causing the immune system to destroy platelets, increasing bleeding risks.
- Antiphospholipid antibody syndrome: A disease that elevates the risk of dangerous blood clots in blood vessels.
How CAR-T Cell Therapy Worked
After previous treatments proved ineffective, she was offered CAR-T cell therapy, a type of "living drug" typically used to treat cancers like leukaemia and lymphoma. This therapy utilises a patient's own immune cells to target and eliminate harmful cells. The medical team extracted her white blood cells, isolated the T-cells—which naturally seek out and destroy abnormal cells—and engineered them to recognise the CD19 protein found on B-cells. These modified T-cells were then re-infused into her body.
The results, detailed in the journal Med, were rapid and profound:
- One week post-treatment, she received her final blood transfusion.
- Two weeks later, she reported feeling stronger.
- Three weeks after therapy concluded, her haemoglobin levels doubled and normalised, indicating her immune system had ceased attacking red blood cells.
Simultaneously, the therapy addressed her other conditions: antiphospholipid antibody levels gradually declined and remained negative, while her platelet counts stabilised.
Potential for Broader Application
Although the patient still exhibits lower white blood cell counts and mild elevations in liver enzymes—likely due to years of prior treatments rather than the CAR-T therapy itself—the recovery has been hailed as a breakthrough. "The speed and depth of the response was remarkable," emphasised Dr. Müller. "We believe that using CAR-T therapy earlier for patients with severe autoimmune disease could help prevent complications from years of ineffective treatments."
He added, "If we can intervene sooner, we may be able to stop the disease process, avoid organ damage, and give patients their lives back." This case underscores the potential of cell therapy to revolutionise treatment for severe autoimmune diseases, offering hope to patients who have struggled with conventional methods.
